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Background: Squamous cell carcinoma accounts for 20% of all human 
lung cancers, and is strongly linked to cigarette smoking. Historically 
it has been the ﬁrst lung cancer associated with distinct premalignant 
intraepithelial changes that evolve through basal cell hyperplasia, squa-
mous metaplasia and increasing dysplasia to carcinoma in situ (CIS) 
and invasive carcinoma. However, it has been difﬁcult to mimic this se-
quence in genetically engineered mice (GEM). Because lung squamous 
cell carcinoma, its progenitor cells (basal cells) and precursor lesions 
express high levels of human keratin 14 (hK14), we hypothesized that 
K14 is critical for squamous differentiation and carcinogenesis in the 
pulmonary epithelium that normally lacks squamous differentiation.
Methods: In order to explore the impact of K14 in the pulmonary 
epithelium that normally lacks both squamous features and K14 immu-
noreactivity, hK14 gene was constitutively expressed in mouse airways 
using Clara cell speciﬁc 10kDa protein (CC10) promoter. In order to 
investigate the effect of hK14 on chemically-induced lung tumorigen-
esis, mice were given tobacco-speciﬁc nitrosamine NNK (4-(methyl-
nitrosoamino)-1-(3-pyridyl)-1-butanol), a major systemic carcinogen 
in cigarettes by intraperitoneal injections (100mg/kg body weight, 3 
times). To further explore the role of hK14 in carcinogenesis, CC10-
hK14 mice were crossed with the previously established CC10-SV40 
TAg mice, a model for aggressive lung carcinomas.
Results: CC10-hK14 transgenic (TG) mice developed normally except 
at the age of 1 year they were 20% lighter (p= 0.014) than their wild 
type (WT) littermates. Light and electron microscopic examination 
of TG mice failed to show any evidence for overt squamous features 
in the airways such as keratinization, intercellular bridges or tonoﬁla-
ments. However, by RT-PCR, quantitative-RT-PCR and immunohis-
tochemistry (IHC), TG mouse lungs were positive for hK14, while 
wild type (WT) lungs did not show any expression. Notably, we also 
detected variable levels of the squamous differentiation markers invo-
lucrin, loricrin, small proline rich proteins and transglutaminase 1, an 
enzyme that mediates corniﬁed cell envelope formation, a hallmark of 
squamous differentiation in TG lungs, while WT lungs were consistent-
ly negative. By 48 weeks the lungs of NNK-exposed TG mice almost 
tripled in weight (p=0.011), contained larger tumors and revealed a 
three-fold increase (p=0.002) in tumor multiplicity compared to the 
lungs of their WT littermates. No tumors were found in saline-ex-
posed control mice. The bi-transgenic CC10-hK14-TAg mice became 
moribund or died of massive lung tumors on average at 18 weeks of 
age. Their lungs typically increased ﬁve-fold in weight and contained 
hK14 by RT-PCR, while the lungs of CC10-SV40 Tag mice had smaller 
tumors that were negative for hK14. While the tumors in TG mice were 
adenomas or adenocarcinomas, they expressed involucrin by IHC. 
Conclusions: Constitutive expression of hK14 initiates squamous 
differentiation program in the mouse lung, which normally lacks K14 
containing cells. Furthermore, it markedly enhances the progression 
of both chemically- and SV40 TAg- induced tumors. Our study is 
signiﬁcant because it provides a novel in vivo model for a common 
premalignant pulmonary lesion in humans, characterized by hK14 
expression and squamous differentiation. It will also be a potentially 
useful pre-clinical tool for chemoprevention research. 
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Purpose: Our previous reports suggest that HPV16/18 infection might 
be an etiological factor of lung cancer in Taiwanese women because 
more than 90% of them are nonsmokers. HPV16 E6 has been shown to 
activate transcription human telomerase reverse transcriptase (hTERT) 
through the increase of binding activity of c-Myc and HIF-1α at 
hTERT promoter. hTERT mRNA has been early detected in preinvasive 
bronchial lesions and atypical adenomatous hyperplasia (AHH) of the 
lung, the prognostic value of hTERT mRNA in lung cancer remains 
conﬂicting. In this study, we sought to determine whether hTERT 
mRNA level could be act as an independent prognostic factor of lung 
cancer, especially in HPV16/18-E6 positive lung cancer patients.
Patients and Methods: hTERT mRNA expressions were performed on 
tumors from 135 lung cancer patients who underwent surgical resec-
tion at Taichung Veterian General Hospital, Taichung, Taiwan. HPV 
16/18 E6 protein expression in lung tumors was detected by immuno-
histochemistry. hTERT mRNA expression levels were determined by 
real-time RT-PCR. Patients’ survival was calculated with univariate, 
Kaplan-Meier, and Cox regression models to identify independent 
prognostic factors. c-Myc, HIF-1α, and E6 proteins in TL1 HPV16 
infected- and TL4 HPV noninfected-lung cancer cell lines, which were 
established from patient’s plural effusions, were determined by Western 
blot. A small interference RNA (RNAi) was used to knockdown E6 of 
TL1 cells to verify whether hTERT transcription could be activated by 
E6 through increased c-Myc and HIF-1α levels. The association of E6 
with c-Myc and HIF-1α in lung tumors were performed on serial paraf-
ﬁn sections of tissue arrays by immunohistochemistry. 
Results: c-Myc and HIF-1α protein expressions in TL1 HPV16 E6 
positive lung cancer cells were higher than in TL4 E6 negative cells. 
In addition, hTERT mRNA level in TL1 cells was higher than in TL4 
cells. When TL1 E6 knocked down by RNAi, c-Myc and HIF-1α 
expression levels were remarkably suppressed and hTERT mRNA level 
was concomitantly reduced compared with those of parental cells. In tu-
mor tissues, hTERT mRNA expression level in E6 positive tumors was 
remarkably higher than in E6 negative tumors. Tissue in vivo showed 
that c-Myc and HIF-1α expressions were marginally correlated with E6 
protein expression. Kaplan-Meier analysis showed that patients with 
higher hTERT mRNA level or E6 positive had greater survival rate than 
those with lower hTERT mRNA (P = 0.004) or E6 negative expression 
(P = 0.016). After adjusted various parameters by Cox regression, a 
higher hTERT mRNA level is still to have favorable prognostic value 
for lung cancer (P = 0.023; RR=0.565). Moreover, the independent 
prognostic value of hTERT mRNA was only observed in E6 positive 
lung cancer (P = 0.007; RR=0.332), not in E6 negative lung cancer.
